Cargando…
Emerging Technologies for Percutaneous Mitral Valve Repair
Mitral regurgitation (MR) is a common disease affecting more than 4 million people in the United States and the European Union. A significant number of percutaneous valves have been developed recently, specifically designed for the mitral anatomy, and with a promising evidence of good procedural and...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6851532/ https://www.ncbi.nlm.nih.gov/pubmed/31781576 http://dx.doi.org/10.3389/fcvm.2019.00161 |
_version_ | 1783469637462130688 |
---|---|
author | Mangieri, Antonio Laricchia, Alessandra Giannini, Francesco Gallo, Francesco Kargoli, Faraj Ladanyi, Annamaria Testa, Luca Colombo, Antonio Latib, Azeem |
author_facet | Mangieri, Antonio Laricchia, Alessandra Giannini, Francesco Gallo, Francesco Kargoli, Faraj Ladanyi, Annamaria Testa, Luca Colombo, Antonio Latib, Azeem |
author_sort | Mangieri, Antonio |
collection | PubMed |
description | Mitral regurgitation (MR) is a common disease affecting more than 4 million people in the United States and the European Union. A significant number of percutaneous valves have been developed recently, specifically designed for the mitral anatomy, and with a promising evidence of good procedural and echocardiographic outcomes. However, even if transcatheter mitral valve replacement (TMVR) will have a role in the future of percutaneous treatment of both functional and degenerative mitral regurgitation, percutaneous mitral valve repair will always play a vital role in the treatment of MR because of the favorable safety profile and the fact that it respects the native anatomy. In this review, we will discuss the new emerging technologies under development to treat mitral regurgitation focusing on different devices that aim to target different components of the mitral anatomy. |
format | Online Article Text |
id | pubmed-6851532 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-68515322019-11-28 Emerging Technologies for Percutaneous Mitral Valve Repair Mangieri, Antonio Laricchia, Alessandra Giannini, Francesco Gallo, Francesco Kargoli, Faraj Ladanyi, Annamaria Testa, Luca Colombo, Antonio Latib, Azeem Front Cardiovasc Med Cardiovascular Medicine Mitral regurgitation (MR) is a common disease affecting more than 4 million people in the United States and the European Union. A significant number of percutaneous valves have been developed recently, specifically designed for the mitral anatomy, and with a promising evidence of good procedural and echocardiographic outcomes. However, even if transcatheter mitral valve replacement (TMVR) will have a role in the future of percutaneous treatment of both functional and degenerative mitral regurgitation, percutaneous mitral valve repair will always play a vital role in the treatment of MR because of the favorable safety profile and the fact that it respects the native anatomy. In this review, we will discuss the new emerging technologies under development to treat mitral regurgitation focusing on different devices that aim to target different components of the mitral anatomy. Frontiers Media S.A. 2019-11-06 /pmc/articles/PMC6851532/ /pubmed/31781576 http://dx.doi.org/10.3389/fcvm.2019.00161 Text en Copyright © 2019 Mangieri, Laricchia, Giannini, Gallo, Kargoli, Ladanyi, Testa, Colombo and Latib. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cardiovascular Medicine Mangieri, Antonio Laricchia, Alessandra Giannini, Francesco Gallo, Francesco Kargoli, Faraj Ladanyi, Annamaria Testa, Luca Colombo, Antonio Latib, Azeem Emerging Technologies for Percutaneous Mitral Valve Repair |
title | Emerging Technologies for Percutaneous Mitral Valve Repair |
title_full | Emerging Technologies for Percutaneous Mitral Valve Repair |
title_fullStr | Emerging Technologies for Percutaneous Mitral Valve Repair |
title_full_unstemmed | Emerging Technologies for Percutaneous Mitral Valve Repair |
title_short | Emerging Technologies for Percutaneous Mitral Valve Repair |
title_sort | emerging technologies for percutaneous mitral valve repair |
topic | Cardiovascular Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6851532/ https://www.ncbi.nlm.nih.gov/pubmed/31781576 http://dx.doi.org/10.3389/fcvm.2019.00161 |
work_keys_str_mv | AT mangieriantonio emergingtechnologiesforpercutaneousmitralvalverepair AT laricchiaalessandra emergingtechnologiesforpercutaneousmitralvalverepair AT gianninifrancesco emergingtechnologiesforpercutaneousmitralvalverepair AT gallofrancesco emergingtechnologiesforpercutaneousmitralvalverepair AT kargolifaraj emergingtechnologiesforpercutaneousmitralvalverepair AT ladanyiannamaria emergingtechnologiesforpercutaneousmitralvalverepair AT testaluca emergingtechnologiesforpercutaneousmitralvalverepair AT colomboantonio emergingtechnologiesforpercutaneousmitralvalverepair AT latibazeem emergingtechnologiesforpercutaneousmitralvalverepair |